Quote:
Originally Posted by Ironhead
|
Not only was the last article mentioned
in vitro studies which I regard as a waste of time reading let alone citing, but this was stated from full text:
"Although 6a-bromoandrostenedione is the most active
compound examined, the aromatase inactivation appears to
be incomplete since 10 to 12% of the enzyme activity remains
after 17 h incubations with 260 and 520 nmol amounts of the
bromoandrogen. We sought to determine if this residual activity
represents a portion of microsomal aromatase that is
protected in some way from the inactivating effect or if some
other microsomal enzyme activity becomes apparent in the
aromatase assay when microsomal aromatase is completely
inactivated.....
.....The amount of [14C]estrone and [I4C]-
17P-estradiol produced during the incubation was measured
after organic solvent extraction and purification by thin-layer
chromatography (Bellino and Osawa, 1974) and countercurrent
distribution analysis (Spaeth and Osawa, 1974). [3H]-
Estrone and [3H]-17P-estradiol were added to the incubation
mixture before organic extraction to correct for the loss in the
procedures. The aromatase specific activity measured by
[ 14C]estrogen production agreed with the tritiated water
measurement. Therefore, the tritiated water production in the
aromatase assay using microsomes preincubated at 4 O C with
260 or 520 nmol of 6a-bromoandrostenedione for 17 h is due
to residual aromatase activity."
Also, a lot of these enzymes and BS were incubated at 4 degrees C which is far from human body temps, another reason to disregard this study. However, if you do want to talk about
in vitro studies as being valid, this is of interesting 'merit' then:
"
A stereospecificity of the inactivation is suggested by the inability
of 6b-bromoandrostenedione to inactivate the enzyme even
though it competitively inhibits androstenedione aromatization
in phosphate buffer and in “S” buffer to an extent equal to that
of the 6a isomer. However, as discussed later, this stereospecificity
of inactivation may be due, at least in part, to the
relative instability of the 6b isomer in “S” buffer."
Moreover another reason to discredit this study....
But wait, it gets better:
"Furthermore, the extent of aromatase inactivation in a mixture of the two isomers,
6-bromoandrostenedione, was intermediate to that found
when the two isomers were incubated individually.
This finding
probably reflects a partial protection of aromatase by the 6b
component since this component apparently is capable of reversibly
binding to the active site and it is present in significant,
though greatly reduced, amounts throughout the 17-h incubation."
Quote:
PA just wants you to believe that 6-OXO is the ONLY solid OTC AI...Oh wait does Ergopharm make that product??
|
I can think on my own, thank you very much.
Quote:
Originally Posted by mmowry
No he wouldnt do that would he? That would be unethical! 
|
The IBE vs. PA mentality still lingers I sea
